When drugs are administered extravascularly, a comprehensive evaluation through noncompartmental analysis becomes imperative. This analytical approach considers various parameters that play a crucial role in understanding the pharmacokinetics of these drugs.

One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area under the concentration-time curve. Doing so provides valuable insights into the drug's mean absorption time (MAT) to reach the systemic circulation and its mean residence time (MRT) within the systemic circulation.

It is worth noting that regardless of the administration route, the mean residence time remains constant. However, the MRT significantly influences the drug's mean absorption and transit times. This observation underscores the importance of considering the residence time when analyzing the pharmacokinetic behavior of extravascularly administered drugs.

In the case of orally administered tablets or capsules, an additional parameter called mean dissolution time (MDT) comes into play. MDT explicitly evaluates the time required for the drug to dissolve in vivo. Its estimation is straightforward for immediate-release-type products, as they exhibit predictable dissolution patterns. In extended-release (ER) formulations, the release of the drug is controlled by various mechanisms, such as matrix systems, coatings, or osmotic pumps, which extend the dissolution process. The extended-release directly increases the MDT compared to immediate-release (IR) formulations.

To calculate the mean dissolution time, we must determine the difference between the mean transit time for a solution and the mean transit time for an immediate-release solid drug product. This distinction provides a valuable indication of the drug's dissolution characteristics and aids in understanding its behavior within the body.

By applying noncompartmental analysis and considering these parameters, researchers and healthcare professionals can understand how extravascularly administered drugs interact with the body, including their transit, absorption, residence, and dissolution processes. This knowledge enables them to make informed decisions regarding dosing regimens, therapeutic efficacy, and potential drug interactions.

Z rozdziału 7:

article

Now Playing

7.28 : Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time

Pharmacokinetic Models

11 Wyświetleń

article

7.1 : Metody analizy danych farmakokinetycznych – podejścia modelowe i niezależne od modelu

Pharmacokinetic Models

21 Wyświetleń

article

7.2 : Podejścia modelowe do danych farmakokinetycznych : modele kompartmentów

Pharmacokinetic Models

15 Wyświetleń

article

7.3 : Jednokomorowy model otwarty do podawania bolusa dożylnego: uwagi ogólne

Pharmacokinetic Models

34 Wyświetleń

article

7.4 : Jednokomorowy model otwarty do podawania dożylnego bolusa: Oszacowanie stałej szybkości eliminacji, okresu półtrwania i objętości dystrybucji

Pharmacokinetic Models

16 Wyświetleń

article

7.5 : Jednokomorowy model otwarty do podawania bolusa dożylnego: ocena klirensu

Pharmacokinetic Models

12 Wyświetleń

article

7.6 : Model jednokomorowy: infuzja dożylna

Pharmacokinetic Models

32 Wyświetleń

article

7.7 : Jednokomorowy model otwarty do podawania pozanaczyniowego: model absorpcji zerowego rzędu

Pharmacokinetic Models

9 Wyświetleń

article

7.8 : Jednokomorowy model otwarty do podawania pozanaczyniowego: model absorpcji pierwszego rzędu

Pharmacokinetic Models

47 Wyświetleń

article

7.9 : Model otwarty jednokomorowy: metoda Wagnera-Nelsona i Loo Riegelmana dla estymacji ka

Pharmacokinetic Models

49 Wyświetleń

article

7.10 : Model otwarty jednokomorowy: dane dotyczące wydalania moczu i oznaczanie k

Pharmacokinetic Models

15 Wyświetleń

article

7.11 : Modele wielokomorowe: Przegląd

Pharmacokinetic Models

8 Wyświetleń

article

7.12 : Model dwukomorowy otwarty: Przegląd

Pharmacokinetic Models

26 Wyświetleń

article

7.13 : Model dwukomorowy otwarty: podawanie bolusa dożylnie

Pharmacokinetic Models

51 Wyświetleń

article

7.14 : Model dwukomorowy otwarty: napar dożylny

Pharmacokinetic Models

57 Wyświetleń

See More

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone